Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Pharyngeal Cancer Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Pharyngeal Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Targeted Therapy 1.4.3 Chemotherapy 1.5 Market by Application 1.5.1 Global Pharyngeal Cancer Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Pharyngeal Cancer Therapeutics Market Perspective (2015-2026) 2.2 Pharyngeal Cancer Therapeutics Growth Trends by Regions 2.2.1 Pharyngeal Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Pharyngeal Cancer Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Pharyngeal Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Pharyngeal Cancer Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Pharyngeal Cancer Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Pharyngeal Cancer Therapeutics Players by Market Size 3.1.1 Global Top Pharyngeal Cancer Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Pharyngeal Cancer Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Pharyngeal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Pharyngeal Cancer Therapeutics Market Concentration Ratio 3.2.1 Global Pharyngeal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Pharyngeal Cancer Therapeutics Revenue in 2019 3.3 Pharyngeal Cancer Therapeutics Key Players Head office and Area Served 3.4 Key Players Pharyngeal Cancer Therapeutics Product Solution and Service 3.5 Date of Enter into Pharyngeal Cancer Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Pharyngeal Cancer Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Type (2021-2026) 5 Pharyngeal Cancer Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 5.2 Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Pharyngeal Cancer Therapeutics Market Size (2015-2020) 6.2 Pharyngeal Cancer Therapeutics Key Players in North America (2019-2020) 6.3 North America Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) 6.4 North America Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Pharyngeal Cancer Therapeutics Market Size (2015-2020) 7.2 Pharyngeal Cancer Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) 7.4 Europe Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Pharyngeal Cancer Therapeutics Market Size (2015-2020) 8.2 Pharyngeal Cancer Therapeutics Key Players in China (2019-2020) 8.3 China Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) 8.4 China Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Pharyngeal Cancer Therapeutics Market Size (2015-2020) 9.2 Pharyngeal Cancer Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) 9.4 Japan Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Pharyngeal Cancer Therapeutics Market Size (2015-2020) 10.2 Pharyngeal Cancer Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Pharyngeal Cancer Therapeutics Market Size (2015-2020) 11.2 Pharyngeal Cancer Therapeutics Key Players in India (2019-2020) 11.3 India Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) 11.4 India Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Pharyngeal Cancer Therapeutics Market Size (2015-2020) 12.2 Pharyngeal Cancer Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 AstraZeneca Plc 13.1.1 AstraZeneca Plc Company Details 13.1.2 AstraZeneca Plc Business Overview and Its Total Revenue 13.1.3 AstraZeneca Plc Pharyngeal Cancer Therapeutics Introduction 13.1.4 AstraZeneca Plc Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020)) 13.1.5 AstraZeneca Plc Recent Development 13.2 Bristol-Myers Squibb Co. 13.2.1 Bristol-Myers Squibb Co. Company Details 13.2.2 Bristol-Myers Squibb Co. Business Overview and Its Total Revenue 13.2.3 Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Introduction 13.2.4 Bristol-Myers Squibb Co. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.2.5 Bristol-Myers Squibb Co. Recent Development 13.3 Eli Lilly and Co. 13.3.1 Eli Lilly and Co. Company Details 13.3.2 Eli Lilly and Co. Business Overview and Its Total Revenue 13.3.3 Eli Lilly and Co. Pharyngeal Cancer Therapeutics Introduction 13.3.4 Eli Lilly and Co. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.3.5 Eli Lilly and Co. Recent Development 13.4 Roche 13.4.1 Roche Company Details 13.4.2 Roche Business Overview and Its Total Revenue 13.4.3 Roche Pharyngeal Cancer Therapeutics Introduction 13.4.4 Roche Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.4.5 Roche Recent Development 13.5 Merck & Co., Inc. 13.5.1 Merck & Co., Inc. Company Details 13.5.2 Merck & Co., Inc. Business Overview and Its Total Revenue 13.5.3 Merck & Co., Inc. Pharyngeal Cancer Therapeutics Introduction 13.5.4 Merck & Co., Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.5.5 Merck & Co., Inc. Recent Development 13.6 Mylan NV 13.6.1 Mylan NV Company Details 13.6.2 Mylan NV Business Overview and Its Total Revenue 13.6.3 Mylan NV Pharyngeal Cancer Therapeutics Introduction 13.6.4 Mylan NV Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.6.5 Mylan NV Recent Development 13.7 Pfizer Inc. 13.7.1 Pfizer Inc. Company Details 13.7.2 Pfizer Inc. Business Overview and Its Total Revenue 13.7.3 Pfizer Inc. Pharyngeal Cancer Therapeutics Introduction 13.7.4 Pfizer Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.7.5 Pfizer Inc. Recent Development 13.8 Sanofi 13.8.1 Sanofi Company Details 13.8.2 Sanofi Business Overview and Its Total Revenue 13.8.3 Sanofi Pharyngeal Cancer Therapeutics Introduction 13.8.4 Sanofi Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.8.5 Sanofi Recent Development 13.9 Sun Pharmaceutical Industries Ltd. 13.9.1 Sun Pharmaceutical Industries Ltd. Company Details 13.9.2 Sun Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue 13.9.3 Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Introduction 13.9.4 Sun Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.9.5 Sun Pharmaceutical Industries Ltd. Recent Development 13.10 Teva Pharmaceutical Industries Ltd. 13.10.1 Teva Pharmaceutical Industries Ltd. Company Details 13.10.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue 13.10.3 Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Introduction 13.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) 13.10.5 Teva Pharmaceutical Industries Ltd. Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Pharyngeal Cancer Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Pharyngeal Cancer Therapeutics Revenue Table 3. Ranking of Global Top Pharyngeal Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Pharyngeal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Targeted Therapy Table 6. Key Players of Chemotherapy Table 7. Global Pharyngeal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Pharyngeal Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Pharyngeal Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Pharyngeal Cancer Therapeutics Market Share by Regions (2015-2020) Table 11. Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Pharyngeal Cancer Therapeutics Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Pharyngeal Cancer Therapeutics Market Growth Strategy Table 17. Main Points Interviewed from Key Pharyngeal Cancer Therapeutics Players Table 18. Global Pharyngeal Cancer Therapeutics Revenue by Players (2015-2020) (Million US$) Table 19. Global Pharyngeal Cancer Therapeutics Market Share by Players (2015-2020) Table 20. Global Top Pharyngeal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharyngeal Cancer Therapeutics as of 2019) Table 21. Global Pharyngeal Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Pharyngeal Cancer Therapeutics Product Solution and Service Table 24. Date of Enter into Pharyngeal Cancer Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 27. Global Pharyngeal Cancer Therapeutics Market Size Share by Type (2015-2020) Table 28. Global Pharyngeal Cancer Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Pharyngeal Cancer Therapeutics Market Size Share by Application (2015-2020) Table 30. Global Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 31. Global Pharyngeal Cancer Therapeutics Market Size Share by Application (2021-2026) Table 32. North America Key Players Pharyngeal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 33. North America Key Players Pharyngeal Cancer Therapeutics Market Share (2019-2020) Table 34. North America Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 35. North America Pharyngeal Cancer Therapeutics Market Share by Type (2015-2020) Table 36. North America Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 37. North America Pharyngeal Cancer Therapeutics Market Share by Application (2015-2020) Table 38. Europe Key Players Pharyngeal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Pharyngeal Cancer Therapeutics Market Share (2019-2020) Table 40. Europe Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 41. Europe Pharyngeal Cancer Therapeutics Market Share by Type (2015-2020) Table 42. Europe Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 43. Europe Pharyngeal Cancer Therapeutics Market Share by Application (2015-2020) Table 44. China Key Players Pharyngeal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 45. China Key Players Pharyngeal Cancer Therapeutics Market Share (2019-2020) Table 46. China Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 47. China Pharyngeal Cancer Therapeutics Market Share by Type (2015-2020) Table 48. China Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 49. China Pharyngeal Cancer Therapeutics Market Share by Application (2015-2020) Table 50. Japan Key Players Pharyngeal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Pharyngeal Cancer Therapeutics Market Share (2019-2020) Table 52. Japan Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 53. Japan Pharyngeal Cancer Therapeutics Market Share by Type (2015-2020) Table 54. Japan Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 55. Japan Pharyngeal Cancer Therapeutics Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Pharyngeal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Pharyngeal Cancer Therapeutics Market Share (2019-2020) Table 58. Southeast Asia Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Pharyngeal Cancer Therapeutics Market Share by Type (2015-2020) Table 60. Southeast Asia Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Pharyngeal Cancer Therapeutics Market Share by Application (2015-2020) Table 62. India Key Players Pharyngeal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 63. India Key Players Pharyngeal Cancer Therapeutics Market Share (2019-2020) Table 64. India Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 65. India Pharyngeal Cancer Therapeutics Market Share by Type (2015-2020) Table 66. India Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 67. India Pharyngeal Cancer Therapeutics Market Share by Application (2015-2020) Table 68. Central & South America Key Players Pharyngeal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Pharyngeal Cancer Therapeutics Market Share (2019-2020) Table 70. Central & South America Pharyngeal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Pharyngeal Cancer Therapeutics Market Share by Type (2015-2020) Table 72. Central & South America Pharyngeal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Pharyngeal Cancer Therapeutics Market Share by Application (2015-2020) Table 74. AstraZeneca Plc Company Details Table 75. AstraZeneca Plc Business Overview Table 76. AstraZeneca Plc Product Table 77. AstraZeneca Plc Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 78. AstraZeneca Plc Recent Development Table 79. Bristol-Myers Squibb Co. Company Details Table 80. Bristol-Myers Squibb Co. Business Overview Table 81. Bristol-Myers Squibb Co. Product Table 82. Bristol-Myers Squibb Co. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 83. Bristol-Myers Squibb Co. Recent Development Table 84. Eli Lilly and Co. Company Details Table 85. Eli Lilly and Co. Business Overview Table 86. Eli Lilly and Co. Product Table 87. Eli Lilly and Co. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 88. Eli Lilly and Co. Recent Development Table 89. Roche Company Details Table 90. Roche Business Overview Table 91. Roche Product Table 92. Roche Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 93. Roche Recent Development Table 94. Merck & Co., Inc. Company Details Table 95. Merck & Co., Inc. Business Overview Table 96. Merck & Co., Inc. Product Table 97. Merck & Co., Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 98. Merck & Co., Inc. Recent Development Table 99. Mylan NV Company Details Table 100. Mylan NV Business Overview Table 101. Mylan NV Product Table 102. Mylan NV Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 103. Mylan NV Recent Development Table 104. Pfizer Inc. Company Details Table 105. Pfizer Inc. Business Overview Table 106. Pfizer Inc. Product Table 107. Pfizer Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 108. Pfizer Inc. Recent Development Table 109. Sanofi Business Overview Table 110. Sanofi Product Table 111. Sanofi Company Details Table 112. Sanofi Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 113. Sanofi Recent Development Table 114. Sun Pharmaceutical Industries Ltd. Company Details Table 115. Sun Pharmaceutical Industries Ltd. Business Overview Table 116. Sun Pharmaceutical Industries Ltd. Product Table 117. Sun Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 118. Sun Pharmaceutical Industries Ltd. Recent Development Table 119. Teva Pharmaceutical Industries Ltd. Company Details Table 120. Teva Pharmaceutical Industries Ltd. Business Overview Table 121. Teva Pharmaceutical Industries Ltd. Product Table 122. Teva Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2015-2020) (Million US$) Table 123. Teva Pharmaceutical Industries Ltd. Recent Development Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharyngeal Cancer Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Targeted Therapy Features Figure 3. Chemotherapy Features Figure 4. Global Pharyngeal Cancer Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Pharyngeal Cancer Therapeutics Report Years Considered Figure 9. Global Pharyngeal Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Pharyngeal Cancer Therapeutics Market Share by Regions: 2020 VS 2026 Figure 11. Global Pharyngeal Cancer Therapeutics Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Pharyngeal Cancer Therapeutics Market Share by Players in 2019 Figure 14. Global Top Pharyngeal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharyngeal Cancer Therapeutics as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Pharyngeal Cancer Therapeutics Revenue in 2019 Figure 16. North America Pharyngeal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Pharyngeal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Pharyngeal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Pharyngeal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Pharyngeal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Pharyngeal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Pharyngeal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. AstraZeneca Plc Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 25. Bristol-Myers Squibb Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Bristol-Myers Squibb Co. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 27. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Eli Lilly and Co. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Roche Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 31. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Merck & Co., Inc. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 33. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Mylan NV Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 35. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Pfizer Inc. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 37. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Sanofi Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 39. Sun Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 41. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2015-2020) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

AstraZeneca Plc Bristol-Myers Squibb Co. Eli Lilly and Co. Roche Merck & Co., Inc. Mylan NV Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd.